| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Delandistrogene moxeparvovec (Elevidys) | 2025-04-28 |
| BCBS Highmark Penn Medicare Advantage | Treatment of Transthyretin-Mediated Amyloidosis | 2025-04-28 |
| BCBS Highmark Penn Medicare Advantage | Interleukin-23 Antagonists | 2025-04-28 |
| Meridian Illinois Medicaid Clinical | Interferon Beta-1a | 2025-04-28 |
| Meridian Illinois Medicaid Clinical | Diroximel Fumarate (Vumerity), Monomethyl Fumarate | 2025-04-27 |
| Meridian Illinois Medicaid Clinical | Alemtuzumab (Lemtrada) | 2025-04-25 |
| Meridian Michigan Medicaid Clinical | CC.PP.011 Code Editing Overview | 2025-04-25 |
| Buckeye Health Plan Ohio Medicaid Clinical | Coding Overview | 2025-04-25 |
| Medicare Novitas | Billing and Coding: Biomarkers for Oncology (52986) | 2025-04-25 |
| Medicare WPS | Billing and Coding: MolDX: Breast Cancer Index® (BCI) Gene Expression Test (56335) | 2025-04-25 |